Apogee Therapeutics Inc company logo
Apogee Therapeutics Inc logo

Apogee Therapeutics Inc (APGE) EBITDA

Annual EBITDA

-$284.18M$67.50M-31.15%

Summary

Current Value
As of today, APGE annual EBITDA is -$284.18M, down -31.15% on
Historical Performance
APGE annual EBITDA is down -824.84% over the past 3 years, down -824.84% over the past 5 years

EBITDA Chart

SUGGESTED SERIES

Performance

APGE Performance
MetricDateValue1Y3Y5Y15Y
Annual EBITDA-$284.18M-31.1%-824.8%-824.8%-824.8%
Quarterly EBITDA-$91.23M-25.4%-383.1%-2019.3%-2019.3%
TTM EBITDA-$322.13M-19.3%-473.7%-7382.6%-7382.6%
Price$135.07+260.0%+576.0%––
PE Ratio-––––
Annual Revenue$0.000.0%0.0%0.0%0.0%
Annual EPS-$4.22-27.7%-436.9%-436.9%-436.9%
-$285.60M-31.7%-829.5%-829.5%-829.5%
Annual Net Income-$255.84M-40.5%-543.1%-543.1%-543.1%

EBITDA Highs

APGE Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y-$30.73MN/AN/A
5Y-$30.73MN/A
All-$30.73MN/A

EBITDA Lows

APGE Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y-$284.18MN/A
5Y-$284.18MN/A
All-$284.18MN/A

EBITDA History

YearValueChange
-$284.18M-31.1%
-$216.68M-133.0%
YearValueChange
-$93.00M-202.7%
-$30.73M-

FAQ

What is the current annual EBITDA of APGE?
As of today, APGE annual EBITDA is -$284.18M
What is 1-year change in APGE annual EBITDA?
APGE annual EBITDA is down -31.15% year-over-year
What is 3-year change in APGE annual EBITDA?
APGE annual EBITDA is down -824.84% over the past 3 years
When is APGE next annual earnings release?
As of today, the next annual earnings release for APGE has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

  1. APGE Official Website www.apogeetherapeutics.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1974640/000197464026000002/0001974640-26-000002-index.htm
  3. APGE Profile on Yahoo Finance finance.yahoo.com/quote/APGE
  4. APGE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/apge